← SynDRA
MITOMYCIN
SynDRA canonical compound SYN0000737 — structure-anchored drug synonym record
| Clinical phase | Launched |
|---|
| Approval status | Approved · Rx/OTC |
|---|
| Mechanism of action | DNA alkylating agent | DNA synthesis inhibitor |
|---|
| Indication | gastric adenocarcinoma | pancreatic cancer |
|---|
| Disease area | oncology |
|---|
All known targets
Mechanisms of action (all sources)
- DNA alkylating agent
- DNA synthesis inhibitor
Drug classes
- Alkylating Activity
- Alkylating Drug
- Alkylating Agents
- Antibiotics, Antineoplastic
- Antineoplastic Agents
- Cross-Linking Reagents
- Enzyme Inhibitors
- Indicators and Reagents
- Noxae
- Nucleic Acid Synthesis Inhibitors
ATC classes
- L01D · CYTOTOXIC ANTIBIOTICS AND RELATED SUBSTANCES
Cross-references
Synonyms
- mutamycin
- Mitomycin C
- Mitomycine
- Mitomicina
- Mitomycin-c
- Ametycine
- Mitocin-c
- Muamycin
- UGN-102
- NSC-26980
- UGN-101
- Jelmyto
- Mitosol
- Mitozytrex
- Mutamycin
- Mytozytrex
- Mitomycin-C
- Mitocin C
- Ametycin
- Mitomycinum
- Mytomycin
- Mitomycinum C
- Mitomycins
- Mitamycin
- MMC
- Mitomycyna C
- 7-Amino-9alpha-methoxymitosane
- NSC 26980
- Mitomycyna C [Polish]
- Mito-C
- Mit-C
- Mitomycin (TN)
- Mitomycinum [INN-Latin]
- Mitomycine [INN-French]
- Mitomicina [INN-Spanish]
- NCI-C04706
- RCRA waste number U010
- NSC26980
Reported adverse events
- Bone marrow suppression
- Rash
- Thrombocytopenia
- Bladder fibrosis
- Cellulitis
- Extravasation
- Headache
- Malaise
- Stomatitis
- Abdominal pain
- Cataract
- Chills
Look up MITOMYCIN in the interactive SynDRA portal →